EMA AI Tool Qualification: How the AIM-NASH App...

By Rene Pretorius

May 19, 2025

The European Medicines Agency (EMA) has issued its first Qualification Opinion (QO) for an
Publication Delays Impact Careers of Early-Career Researchers
EFPIA Advocates for Stronger Life Sciences in EU Multiannual Financial Framework
Evolving NICE Health Technology Evaluations: Enhancing Patient Perspectives a...
Bulevirtide HDV Therapy: Promising Results in Durable Virologic Control
FDA AI Drug Approval
HCV Treatment Advancements: Atea Pharmaceuticals KOL Panel
Empowering Health: The Role of Self-Care and NCDs in Global Health Policy
ZEVASKYN Gene Therapy: A Breakthrough for Recessive Dystrophic Epidermolysis ...
Enhancing Pediatric Pain Management in Portuguese Emergency Departments: Prog...
Urgent Need for Pediatric Heart Devices
FDA Approves Perioperative Immunotherapy for Bladder Cancer: A Breakthrough i...
Navigating Drug Price Regulation: Evaluating the Executive Order’s Pote...